| Taxifolin/ergothioneine and Immune Biomarkers in Healthy Volunteers (TaxEr) | A Pilot Study of Dietary Taxifolin/Dihydroquercetin and Ergothioneine and Immune Biomarkers in Healthy Volunteers | NCT05190432 |
| Repletion of Ergothioneine in Patients With Kidney Failure | Repletion of Ergothioneine in Patients With Kidney Failure | NCT06487546 |
| A randomized, open-label, parallel, self-controlled clinical trial of ergothioneine eyewash for the improvement of ocular discomfort | A randomized, open-label, parallel, self-controlled clinical trial of ergothioneine eyewash for the improvement of ocular discomfort | ChiCTR2400090987 |
| Effect of Continuous Intake of Ergothioneine-containing Supplements on Skin Condition | Effect of Continuous Intake of Ergothioneine-containing Supplements on Skin Condition: a Randomized, Double Blind, Placebo-controlled Study | NCT06886061 |
| Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women | A Placebo-controlled, Randomized, Double-blind Trial to Assess the Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women | NCT04556032 |
| A Study on the Efficacy and Safety of Ergothioneine Capsules in Improving Ovarian Reserve Function | A Study on the Efficacy and Safety of Ergothioneine Capsules in Improving Ovarian Reserve Function | ChiCTR2500104484 |
| A Study on the Efficacy and Safety of Ergothioneine Capsules for Carotid Atherosclerosis | A Study on the Efficacy and Safety of Ergothioneine Capsules for Carotid Atherosclerosis | ChiCTR2500104802 |
| A randomised study with placebo control to assess the effects of Ergothioneine (ERG-001) on Cognition, Mood and Sleep in both adult men and woman aged between 55 and 79 years of age. | A Placebo-controlled, Randomized, Double-blind Trial to Assess the Effects of Ergothioneine (ERG-001) on Cognition, Mood, and Sleep in Adult Men and Women at 4 and 16 weeks. | ACTRN12621001607864 |
| Investigating the Efficacy of Ergothioneine to Delay Cognitive Decline (Pilot) | Pilot Study to Investigate the Efficacy of Ergothioneine to Delay Cognitive Decline in Mild Cognitively Impaired Subjects | NCT03641404 |
| Investigating the potential health benefits of ergothioneine supplementation for people with metabolic syndrome | A randomised, double-blind, placebo-controlled pilot study investigating the effects of 12 weeks ergothioneine supplementation on serum oxidative, inflammatory, and metabolic markers in people with metabolic syndrome | ISRCTN25890011 |
